Management of Hepatitis C Infection
Summary
- AASLD/IDSA guidelines recommend DAA-based regimens for genotype 1 HCV–infected patients according to subgenotype, presence of baseline NS5A resistance associated mutations, and cirrhosis status (Table 24) (Table 25) (Management Guidelines)[AASLD-IDSA HCV]
- EASL guidelines also recommend DAA-based regimens for treatment-naive and interferon/ribavirin-experienced patients with genotype 1 HCV infection according to subgenotype and cirrhosis status (Table 26) (Management Guidelines)[EASL HCV]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Hepatitis C-Treatment